DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/1484
Title: Full time occlusion VS part time occlusion in treatment of monocular amblyopia
Authors: Mehboob, Mohammad Asim
Muhammad, Shoaib
Farooq, Muhammad Asad
Keywords: Medical and Health Sciences
Amblyopia
Full time occlusion
Part time occlusion
Issue Date: 1-Jan-2019
Publisher: Pak J Med Sci
Abstract: Objective: To compare improvement in Best Corrected Visual Acuity (BCVA) by Full Time Occlusion (FTO) or Part Time Occlusion (PTO) technique in children with monocular amblyopia. Methods: This randomized control trial was conducted at Combined Military Hospital, Gujranwala from April 2018 to June 2019. A total of 52 children, diagnosed with non-pathological ametropic amblyopia were randomly divided in two groups. Both underwent cycloplegic refraction and assessment of BCVA. Group A underwent FTO for eight weeks with patch removal only during sleep. Group B underwent PTO for eight weeks with patching done for six hours a day, out of which 1-2 hours were utilized in near work. Final BCVA was checked at eight weeks, and compared between two groups. Results: Mean age of study population was 11.06±3.30 years. Mean BCVA before amblyopia treatment was 0.70±0.20 logMAR, and mean BCVA after eight weeks of amblyopia treatment in both groups was 0.29±0.18 logMAR. Difference in BCVA between both groups was statistically significant (p= 0.023). Mean improvement in lines on Snellen’s Visual acuity chart was 1.92±1.35 lines. In our study, 92% of children in FTO group and 66.6% of children in PTO group achieved BCVA of 6/12 or better. Conclusions: Full time occlusion in children with monocular amblyopia results in greater improvement in BCVA as compared to part time occlusion of six hours per day.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/1484
Appears in Collections:Journals

Files in This Item:
File Description SizeFormat 
321.htm130 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.